INTERPLAY BETWEEN VITAMIN D STATUS AND ANTIVIRAL THERAPY AMONG CHRONIC HEPATITIS C EGYPTIAN PATIENTS | ||||
Journal of the Egyptian Society of Parasitology | ||||
Article 3, Volume 45, Issue 1, April 2015, Page 17-22 PDF (161.34 K) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/jesp.2015.89679 | ||||
View on SCiNiTO | ||||
Authors | ||||
MOUSTAFA HAMED ABD ELALIM1; DOAA ZAKARIA ZAKY1; IBRAHIM ABD EL GHANY MOTAWAE2; NESREEN A MOHAMED3; ADLY NABIH NAGIB | ||||
1Department of Tropical Medicine, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt. | ||||
2Department of Internal Medicine, Faculty of Medicine, El-Menia University, El-Menia, Egypt. | ||||
3Department of Clinical Pathology, Faculty of Medicine, | ||||
Abstract | ||||
Vitamin D has been shown to play an important immunomodulatory role; deficiency of vitamin D has been recently associated to the lack of response to antiviral therapy in chronic hepatitis C patients. This study evaluated the interrelationship between serum level of vitamin D and early response to antiviral therapy in Egyptian patients with chronic HCV infection. A total of 45 patients with chronic HCV infection who received antiviral treatment (Pegylated interferon and Ribavirin), their vitamin D serum level was assessed once at the start of treatment and 12 weeks later, when the EVR was determine by Quantitative HCV-RNA by PCR. The results showed that vitamin D status has no correlation with viral load and hepatitis activity by biopsy and without significant association between vitamin D deficiency and the antiviral therapy response. However, there was significance improvement in level of vitamin D after 12 weeks of receiving the antiviral therapy of HCV. | ||||
Keywords | ||||
Egypt; Chronic Hepatitis C Patients; Vitamin D; Antiviral Therapy | ||||
Statistics Article View: 133 PDF Download: 112 |
||||